Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference123 articles.
1. The frequency and clinical impact of HER2 alterations in lung adenocarcinoma;Kim;PLoS One,2017
2. Lung cancer: intragenic ERBB2 kinase mutations in tumours;Stephens;Nature,2004
3. HER kinase inhibition in patients with HER2- and HER3-mutant cancers;Hyman;Nature,2018
4. The neu oncogene encodes an epidermal growth factor receptor-related protein;Bargmann;Nature,1986
5. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas;Arcila;Clin Cancer Res,2012
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel circular RNA hsa_circ_0036683 suppresses proliferation and migration by mediating the miR‐4664‐3p/CDK2AP2 axis in non‐small cell lung cancer;Thoracic Cancer;2024-08-07
2. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27
3. HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging Strategies;Cancers;2024-05-26
4. ERBB2 Amplification in NSCLC: How Many Faces?;Journal of Thoracic Oncology;2024-05
5. HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies;Life;2023-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3